European Respiratory Review最新文献

筛选
英文 中文
From silicosis to sarcoid-like reaction: a continuum model of silica-induced lung disease. 从矽肺到结节样反应:矽肺诱发肺部疾病的连续模型
IF 10.8 1区 医学
European Respiratory Review Pub Date : 2026-11-04 Print Date: 2026-10-01 DOI: 10.1183/16000617.0153-2026
Metin Akgün, Alperen Aksakal, Ozlem Kar Kurt
{"title":"From silicosis to sarcoid-like reaction: a continuum model of silica-induced lung disease.","authors":"Metin Akgün, Alperen Aksakal, Ozlem Kar Kurt","doi":"10.1183/16000617.0153-2026","DOIUrl":"10.1183/16000617.0153-2026","url":null,"abstract":"<p><p>The term \"sarcoidosis\", coined in 1899 from the Greek <i>sarx</i> (flesh) and -<i>oid</i> (resembling), is descriptive and conveys no aetiological information. When a trigger has been identified for a granulomatous condition previously considered idiopathic, nomenclature has tended to shift from descriptive to aetiological, as when \"Salem sarcoid\" was reclassified as chronic beryllium disease (CBD). Crystalline silica exposure has been associated with sarcoidosis in several occupational cohorts, and partially overlapping immunopathogenic pathways have been described, notably NLR family pyrin domain containing 3 (NLRP3) inflammasome activation and T-helper cell 17.1 (Th17.1) polarisation, neither of which is disease-specific. The available evidence is consistent with a continuum model of silica-induced lung disease spanning a silicotic fibrotic phenotype (classical silicosis, driven by NLRP3 and transforming growth factor-β1 signalling), a granulomatous phenotype (silica-induced sarcoid-like reaction (SISLR), driven by NLRP3, interleukin-1β and Th17.1 signalling in susceptible individuals) and a mixed phenotype in which both processes coexist. The silica lymphocyte proliferation test (Si-LPT) has detected <i>in vitro</i> immunoreactivity in a subset of patients with sarcoidosis but is not standardised. The CBD paradigm offers useful analogies, although beryllium-driven adaptive and silica-driven innate mechanisms differ in important respects. SISLR may serve as a working classification that identifies the putative trigger, supports occupational disease recognition and situates the granulomatous response within a broader continuum; we discuss it alongside the alternative \"silicosarcoidosis\" terminology. On the evidence reviewed, crystalline silica should no longer be treated as an incidental co-exposure in a patient with sarcoid-type granulomas. A documented exposure warrants classification as occupationally related granulomatous lung disease and standardising the Si-LPT is the immediate priority.</p>","PeriodicalId":12166,"journal":{"name":"European Respiratory Review","volume":"35 182","pages":""},"PeriodicalIF":10.8,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13732409/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149333099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The context and mechanisms that contribute to accessible and engaging asthma care: a rapid realist review. 有助于获得和参与哮喘护理的背景和机制:快速现实主义回顾。
IF 10.8 1区 医学
European Respiratory Review Pub Date : 2026-11-04 Print Date: 2026-10-01 DOI: 10.1183/16000617.0042-2026
Emma Kinley, Hilary Pinnock, Huayi Huang, Jessica Sheringham, David Lo, Irtiza Qureshi, Tracy Jackson, Jennifer Quint, Constantinos Kallis, Gwyneth A Davies, Erol A Gaillard, Purva Abhyankar
{"title":"The context and mechanisms that contribute to accessible and engaging asthma care: a rapid realist review.","authors":"Emma Kinley, Hilary Pinnock, Huayi Huang, Jessica Sheringham, David Lo, Irtiza Qureshi, Tracy Jackson, Jennifer Quint, Constantinos Kallis, Gwyneth A Davies, Erol A Gaillard, Purva Abhyankar","doi":"10.1183/16000617.0042-2026","DOIUrl":"https://doi.org/10.1183/16000617.0042-2026","url":null,"abstract":"<p><strong>Introduction: </strong>Access to and engagement with asthma care could improve outcomes, but there is limited understanding of the reasons for poor engagement and a gap in actionable evidence to inform how to reduce inequities. We aimed to understand the context, mechanisms and outcomes (CMOs) that affect access to and engagement with asthma care and to identify solutions.</p><p><strong>Methods: </strong>Using rapid realist review methodology, we searched four databases (1999-2024) for studies of any design in asthma populations (>5 years of age) that explored access or engagement in healthcare applicable to the UK health context. We extracted CMO configurations explaining access and engagement with asthma services and synthesised them into overarching theories. External reference group meetings with 16 experts with lived experience and professional expertise were held to discuss preliminary review findings and inform their interpretation.</p><p><strong>Results: </strong>19 articles reported 16 studies. We identified eight theories from 51 CMOs, grouped under two themes. 1) Demographic and social-cognitive barriers, including socioeconomic and structural barriers, uncertain candidacy resulting in escalation to emergency care, low perceived need hindering engagement and relational accountability driving engagement. 2) Health system barriers, including over-burdened services, fragmented systems disrupting care, feeling unheard hindering youth engagement, and cultural and language barriers. Solutions included digital care, education, developing patient skills, proactive follow-up, training for healthcare professionals, information sharing between services and enhanced professional-patient relationships.</p><p><strong>Conclusion: </strong>Enhancing system coordination, cultural sensitivity and patient-centredness of care may improve trust and patient-provider communication, leading to better engagement and proactive asthma care.</p>","PeriodicalId":12166,"journal":{"name":"European Respiratory Review","volume":"35 182","pages":""},"PeriodicalIF":10.8,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149333101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Climate change as a modifier of paediatric lung-function trajectories. 气候变化是儿童肺功能轨迹的调节因子。
IF 10.8 1区 医学
European Respiratory Review Pub Date : 2026-11-04 Print Date: 2026-10-01 DOI: 10.1183/16000617.0222-2026
David Drummond, Harald E Renz, Cihan Beri, Maria José Rosa, Jaime E Hart, Mark P Murphy, Noel G McElvaney
{"title":"Climate change as a modifier of paediatric lung-function trajectories.","authors":"David Drummond, Harald E Renz, Cihan Beri, Maria José Rosa, Jaime E Hart, Mark P Murphy, Noel G McElvaney","doi":"10.1183/16000617.0222-2026","DOIUrl":"10.1183/16000617.0222-2026","url":null,"abstract":"<p><p>Lung function follows a life-course trajectory, rising through childhood and adolescence to a peak in early adulthood; a low peak is associated with later COPD, cardiovascular morbidity and premature mortality. Childhood and adolescence are therefore the key periods during which adult respiratory reserve is built. Climate change is relevant to paediatric respiratory health not only because it triggers acute symptoms, but because it intensifies, prolongs and reschedules exposures already known to affect the developing lung, including heat, air pollution, wildfire smoke, aeroallergens and indoor damp. In this mini-review, we use lung-function trajectories as the organising framework and examine how climate-sensitive exposures may shift them downwards through three developmental pathways. First, early developmental disruption, including gestational air pollution and ambient temperature, may lower the starting point of the trajectory through fetal growth restriction, preterm birth and possibly direct effects on developing airways. Second, sustained exposure to air pollution, heat and indoor dampness across childhood and adolescence may impair postnatal lung growth and reduce lung-function growth and the peak attained. Third, climate-sensitive triggers increasingly precipitate exacerbations followed by incomplete recovery, particularly in asthma and cystic fibrosis, resulting in exacerbation-related step-down events. Crucially, these trajectories are not fixed; evidence that improving air quality accelerates lung-function growth shows that respiratory reserve can still be protected. We translate this trajectory-centred evidence into practical, climate-aware paediatric care, shifting the focus from short-term symptom prevention to preserving the lung-function reserve children carry into adulthood.</p>","PeriodicalId":12166,"journal":{"name":"European Respiratory Review","volume":"35 182","pages":""},"PeriodicalIF":10.8,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13732408/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149333098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment strategies for obliterative bronchiolitis associated with connective tissue diseases: a scoping review. 结缔组织疾病相关闭塞性细支气管炎的治疗策略:范围综述
IF 10.8 1区 医学
European Respiratory Review Pub Date : 2026-11-04 Print Date: 2026-10-01 DOI: 10.1183/16000617.0073-2026
Rangdol Tenzin Rangdol, Ewa Mia Dlikowska, Arno Vanstapel, Catharina Belge, Ellen De Langhe, Laurens De Sadeleer, Nico De Crem, Wojciech J Piotrowski, Wim A Wuyts
{"title":"Treatment strategies for obliterative bronchiolitis associated with connective tissue diseases: a scoping review.","authors":"Rangdol Tenzin Rangdol, Ewa Mia Dlikowska, Arno Vanstapel, Catharina Belge, Ellen De Langhe, Laurens De Sadeleer, Nico De Crem, Wojciech J Piotrowski, Wim A Wuyts","doi":"10.1183/16000617.0073-2026","DOIUrl":"10.1183/16000617.0073-2026","url":null,"abstract":"<p><p>Obliterative bronchiolitis associated with connective tissue diseases (OB-CTD) is a severe and progressive pulmonary condition. Characterised by inflammation and fibrosis of the small airways, it leads to significant morbidity. Despite its severity, OB-CTD often remains underdiagnosed and the lack of standardised, evidence-based treatment guidelines poses a substantial clinical challenge. This scoping review consolidates current knowledge of the treatment of OB-CTD. The review aims to raise awareness and stimulate targeted research to improve patient outcomes. Current therapeutic regimens consist of empirical combinations of corticosteroids and various immunomodulatory agents, but their efficacy is inconsistent and supported by limited robust evidence. While supportive care, pulmonary rehabilitation and ultimately lung transplantation are key components of advanced disease management, this review highlights the critical need for effective, validated therapies. Emerging treatments, including antifibrotics, biologic therapies (targeting B-cells or tumour necrosis factor-α), Janus kinase inhibitors and phosphodiesterase-4B inhibitors, show promise but require rigorous investigation in the OB-CTD cohort. To advance the management of this challenging disease, future research must prioritise well-designed, large-scale studies on early diagnostic markers, distinct patient phenotypes, and novel therapeutic interventions.</p>","PeriodicalId":12166,"journal":{"name":"European Respiratory Review","volume":"35 182","pages":""},"PeriodicalIF":10.8,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13732411/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149333102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"Neuroplasticity and neuroimmune interactions with type 2 inflammation in asthma." C.S. Koster, C. Lavitola, R. Teodorescu, et al. Eur Respir Rev 2026; 35: 250159. “神经可塑性和神经免疫与哮喘2型炎症的相互作用。”C. s . Koster, C. Lavitola, R. Teodorescu,等。欧洲呼吸Rev 2026;35: 250159。
IF 10.8 1区 医学
European Respiratory Review Pub Date : 2026-11-04 Print Date: 2026-10-01 DOI: 10.1183/16000617.5159-2025
{"title":"\"Neuroplasticity and neuroimmune interactions with type 2 inflammation in asthma.\" C.S. Koster, C. Lavitola, R. Teodorescu, <i>et al</i>. <i>Eur Respir Rev</i> 2026; 35: 250159.","authors":"","doi":"10.1183/16000617.5159-2025","DOIUrl":"10.1183/16000617.5159-2025","url":null,"abstract":"","PeriodicalId":12166,"journal":{"name":"European Respiratory Review","volume":"35 182","pages":""},"PeriodicalIF":10.8,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13732406/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149333097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health-related quality of life measures in chronic pulmonary aspergillosis: a systematic review of psychometric validity. 慢性肺曲霉病的健康相关生活质量测量:心理测量效度的系统评价。
IF 10.8 1区 医学
European Respiratory Review Pub Date : 2026-11-04 Print Date: 2026-10-01 DOI: 10.1183/16000617.0039-2026
Dareen Marghlani, Aran Singanayagam, Zhifang Melody Ni, Darius Armstrong-James, Anand Shah
{"title":"Health-related quality of life measures in chronic pulmonary aspergillosis: a systematic review of psychometric validity.","authors":"Dareen Marghlani, Aran Singanayagam, Zhifang Melody Ni, Darius Armstrong-James, Anand Shah","doi":"10.1183/16000617.0039-2026","DOIUrl":"10.1183/16000617.0039-2026","url":null,"abstract":"<p><strong>Background/objective: </strong>Chronic pulmonary aspergillosis (CPA) is a chronic progressive fungal lung infection associated with global mortality and impact on health-related quality of life (HRQoL). HRQoL tools are valuable in disease management and as trial end-points; however, use in CPA has not been systematically analysed. We analyse CPA-specific symptoms and strengths and limitations of currently used HRQoL tools focusing on psychometric validity.</p><p><strong>Methods: </strong>A systematic review of studies reporting HRQoL tools or symptom scores in CPA and published in English (inception to May 2025) was conducted. Eligible studies were categorised into two groups, those employing HRQoL questionnaires (questionnaire-based studies (QBS) and those reporting CPA symptoms to analyse content validity. Narrative synthesis followed Synthesis Without Meta-analysis (SWiM) reporting guidance.</p><p><strong>Results: </strong>Of 520 studies identified, 64 met inclusion criteria, including 18 QBS. Only generic tools have measured HRQoL in CPA, with St. George's Respiratory Questionnaire (SGRQ) the most common. SGRQ demonstrated excellent internal consistency (Cronbach's alpha 0.94), test-retest reliability (intraclass correlation coefficient 0.97) and an anchor-based minimal clinically important difference of 7.3 points; an >8-unit change in the SGRQ symptoms domain discriminated clinical recurrence at 12 months with 90.9% sensitivity and 87.0% specificity. Significant limitations however remain regarding content validity and usability. Other HRQoL tools or symptom scores used had minimal psychometric validity.</p><p><strong>Conclusion: </strong>Current CPA HRQoL tools are generic with SGRQ the only tool with psychometric validity but limitations in content validity and usability highlighting the need for development of a CPA-specific HRQoL tool to aid clinical monitoring and standardisation of therapeutic end-points.</p>","PeriodicalId":12166,"journal":{"name":"European Respiratory Review","volume":"35 182","pages":""},"PeriodicalIF":10.8,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13732414/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149333100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interventions to increase participation in lung cancer screening programmes: a systematic review and meta-analysis. 增加肺癌筛查项目参与的干预措施:系统回顾和荟萃分析。
IF 10.8 1区 医学
European Respiratory Review Pub Date : 2026-10-21 Print Date: 2026-10-01 DOI: 10.1183/16000617.0108-2026
Olivera Djuric, Andrea Guida, Francesca Bononi, Francesco Venturelli, Maria Chiara Bassi, Giuseppe Gorini, Eugenio Paci, Paola Mantellini, Paolo Giorgi Rossi
{"title":"Interventions to increase participation in lung cancer screening programmes: a systematic review and meta-analysis.","authors":"Olivera Djuric, Andrea Guida, Francesca Bononi, Francesco Venturelli, Maria Chiara Bassi, Giuseppe Gorini, Eugenio Paci, Paola Mantellini, Paolo Giorgi Rossi","doi":"10.1183/16000617.0108-2026","DOIUrl":"10.1183/16000617.0108-2026","url":null,"abstract":"<p><strong>Introduction: </strong>We aimed to systematically review and meta-analyse the effectiveness of interventions in increasing informed choice and participation in lung cancer screening based on low-dose computed tomography (LDCT).</p><p><strong>Methods: </strong>Five electronic databases, Medline (PubMed version), Embase, Cinahl (Ebsco version), Scopus and Cochrane CENTRAL, were searched for randomised controlled trials, nonrandomised controlled trials and before-after studies published from 2000 until 15 March 2023. A random-effects meta-analysis was conducted to assess the effectiveness of interventions to increase rates of LDCT completion.</p><p><strong>Results: </strong>Out of 3483 studies identified, 14 completed and 21 ongoing studies were included in the review. Shared-decision making (SDM)+navigation (OR 4.34, 95% CI 2.50-7.54) and outreach+navigation (OR 2.20, 95% CI 1.70-2.84) resulted in a higher proportion of LDCT performed compared to the control group. Educational/informational interventions (OR 1.03, 95% CI 0.89-1.19) as well as SDM alone (OR 1.15, 95% CI 0.57-2.32) did not improve LDCT uptake, despite the second improving decisional outcomes in both intervention and control groups. Multicomponent interventions showed significantly higher LDCT uptake (OR 2.64, 95% CI 1.79-3.90), compared to unicomponent interventions (OR 1.00, 95% CI 0.87-1.14). The vast majority of interventions, including those in ongoing trials, are patient-oriented, while community-based, provider-level and system-level interventions remain rare.</p><p><strong>Conclusions: </strong>Combining high-intensity patient-oriented interventions, such as patient navigation, active outreach and SDM, appears to be the most promising strategy to increase lung cancer screening uptake (low certainty of evidence). However, implementation studies are needed to evaluate interventions targeting both provider and healthcare systems level.</p>","PeriodicalId":12166,"journal":{"name":"European Respiratory Review","volume":"35 182","pages":""},"PeriodicalIF":10.8,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684418/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149237338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Geriatric respiratory medicine 2026: from artificial intelligence to personalised management of the multimorbid patient. 老年呼吸医学2026:从人工智能到多病患者的个性化管理。
IF 10.8 1区 医学
European Respiratory Review Pub Date : 2026-10-21 Print Date: 2026-10-01 DOI: 10.1183/16000617.0115-2026
Claudio Sorino, Paolo Cameli, Giorgio Walter Canonica, Giovanna Elisiana Carpagnano, Andrea Cortegiani, Claudio Costantino, Danilo Di Bona, Mario Malerba, Andrea Maresca, Corrado Pelaia, Stefania Principe, Beatrice Ragnoli, Paola Rogliani, Simone Scarlata, Alessandra Tomasello, Luigi Tramonte, Antonino Tuttolomondo, Alessandro Vatrella, Patrizio Vitulo, Anna Zito, Nicola Scichilone
{"title":"Geriatric respiratory medicine 2026: from artificial intelligence to personalised management of the multimorbid patient.","authors":"Claudio Sorino, Paolo Cameli, Giorgio Walter Canonica, Giovanna Elisiana Carpagnano, Andrea Cortegiani, Claudio Costantino, Danilo Di Bona, Mario Malerba, Andrea Maresca, Corrado Pelaia, Stefania Principe, Beatrice Ragnoli, Paola Rogliani, Simone Scarlata, Alessandra Tomasello, Luigi Tramonte, Antonino Tuttolomondo, Alessandro Vatrella, Patrizio Vitulo, Anna Zito, Nicola Scichilone","doi":"10.1183/16000617.0115-2026","DOIUrl":"10.1183/16000617.0115-2026","url":null,"abstract":"<p><p>The profound demographic shift toward an ageing population has decisively moved the burden of chronic and acute lung diseases towards older adults, necessitating a transition from organ-centred models to integrated, multidimensional care. This review outlines a pragmatic framework for managing the complex interplay of immunosenescence, frailty and multimorbidity. In acute care, \"pneumonia-associated sarcopenia\" is identified as a critical driver of recurrent infections and functional decline, requiring a shift towards aspiration prevention and the aid of diagnostic tools such as lung ultrasound. The selection of noninvasive respiratory support, including high-flow nasal cannulas and noninvasive ventilation, must balance physiological efficacy with the risks of delirium and patient self-inflicted lung injury. Preventive strategies have evolved with the introduction of 20-valent pneumococcal and respiratory syncytial virus vaccines, alongside proactive screening for ɑ1-antitrypsin deficiency to enable precision interventions. Chronic disease management emphasises a \"device-centric\" inhalation therapy approach, tailoring delivery systems to impaired peak inspiratory flows and cognitive status rather than to pharmacology alone. The advent of biological therapies, particularly the use of dupilumab and mepolizumab in eosinophilic COPD, offers a transformative \"steroid-sparing\" effect, aiming for clinical stability and preserved independence. Finally, the integration of artificial intelligence as \"augmented intelligence\" and the \"4Ms\" multidisciplinary model (mentation, medication, mobility, morbidities) provide the necessary tools to navigate clinical complexity. This holistic strategy ensures that technological innovation remains anchored in patient-centred goals.</p>","PeriodicalId":12166,"journal":{"name":"European Respiratory Review","volume":"35 182","pages":""},"PeriodicalIF":10.8,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684414/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149237392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carcinoids of the lung caused by exogenous noxious agents: a scoping review. 外源性有毒物质引起的肺类癌:范围综述。
IF 10.8 1区 医学
European Respiratory Review Pub Date : 2026-10-21 Print Date: 2026-10-01 DOI: 10.1183/16000617.0145-2026
Sonja Kilo, Christin Schröder, Ludwig Frei-Stuber, Karl-Heinz Jöckel, Danny Jonigk, Florian Länger, Dennis Nowak
{"title":"Carcinoids of the lung caused by exogenous noxious agents: a scoping review.","authors":"Sonja Kilo, Christin Schröder, Ludwig Frei-Stuber, Karl-Heinz Jöckel, Danny Jonigk, Florian Länger, Dennis Nowak","doi":"10.1183/16000617.0145-2026","DOIUrl":"10.1183/16000617.0145-2026","url":null,"abstract":"<p><strong>Background: </strong>Approximately 2% of lung tumours are pulmonary carcinoids (PCs), divided into typical (90%) and atypical (AC) (10%). The link with external exposure to carcinogens remains controversial.</p><p><strong>Objective: </strong>To investigate the association between occupational exposure to carcinogens and PC tumours.</p><p><strong>Methods: </strong>A PRISMA-ScR-guided scoping review was performed. A systematic search was conducted in PubMed and Embase (January 2025). Studies were reviewed, data extracted, analysed and summarised narratively.</p><p><strong>Results: </strong>1302 studies were reviewed. 27 original studies and seven conference papers on topics including exposure to cigarette smoke (n=23) and asbestos (n=6), or mechanistic information, were included. Following the collapse of the World Trade Center in 2001, carcinoids accounted for 6% of lung cancer cases in people exposed to the resulting dust (9% in women, 3% in men). The proportion of ACs among carcinoids rose from 9.3% (controls) to 16.3% (smokers) and from ∼25% to 45% (probable <i>versus</i> definite asbestos exposure). Basic research has identified biological pathways linking harmful exposures (such as asbestos and cigarette smoke) to neuroendocrine cell proliferation and the potential progression of PCs to higher-grade lung tumours.</p><p><strong>Discussion: </strong>The significance these of findings is limited due to 1) the limited number of studies, 2) the small number of tumours within those studies and 3) the lack of rigid diagnostic (morphological and molecular) criteria for PCs in most studies. Nevertheless, a consistent finding is a higher proportion of AC among carcinoids, particularly following asbestos exposure.</p><p><strong>Conclusions: </strong>Based on these findings, a link between carcinogenic substances (especially asbestos and cigarette smoke) and carcinoids seems plausible. More stringent analyses in epidemiological surveys are needed to further clarify the pathogenesis of PCs.</p>","PeriodicalId":12166,"journal":{"name":"European Respiratory Review","volume":"35 182","pages":""},"PeriodicalIF":10.8,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684415/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149237376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Haemoptysis in chronic pulmonary vascular disease: a narrative review. 慢性肺血管疾病的咯血:一个叙述性的回顾。
IF 10.8 1区 医学
European Respiratory Review Pub Date : 2026-10-21 Print Date: 2026-10-01 DOI: 10.1183/16000617.0055-2026
Jan C Kamp, Brandon Budhram, Mitja Jevnikar, Karen M Olsson, Matti J Peperhove, Lavinia Neubert, Marius M Hoeper, Marc Humbert
{"title":"Haemoptysis in chronic pulmonary vascular disease: a narrative review.","authors":"Jan C Kamp, Brandon Budhram, Mitja Jevnikar, Karen M Olsson, Matti J Peperhove, Lavinia Neubert, Marius M Hoeper, Marc Humbert","doi":"10.1183/16000617.0055-2026","DOIUrl":"10.1183/16000617.0055-2026","url":null,"abstract":"<p><p>Haemoptysis, the expectoration of blood from the lower airways, is a complication of several pulmonary vascular diseases (PVDs). The pathophysiology of haemoptysis in chronic PVDs is complex and varies depending on the underlying condition. Computed tomography pulmonary angiography remains the gold standard for localising the bleeding source and guiding interventional therapies. Management of haemoptysis in patients with chronic PVDs can range from oxygen supplementation to angiography-guided bronchial artery embolisation, depending on bleeding severity, anatomical features and specific features of the associated disease. Regardless of the management strategy, long-term follow-up is essential in these patients owing to the risk of recurrent bleeding. The aim of this review is to comprehensively explore the characteristics of haemoptysis in selected chronic PVDs, summarise current knowledge of the pathophysiology, and provide guidance on contemporary diagnostic and treatment strategies.</p>","PeriodicalId":12166,"journal":{"name":"European Respiratory Review","volume":"35 182","pages":""},"PeriodicalIF":10.8,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684417/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149237390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书